Dennis Thompson of Health Day News recently reported that Dr. Shimrit Uliel-Sibony heads up the epilepsy service at Tel Aviv Sourasky Medical Center’s Dana-Dwek Children’s Hospital in Israel. He recently led a study that reveals that a marijuana-derived drug that helps control epileptic seizures appears to become less effective over time in some patients.  Apparently through Dr. Uliel-Sibony’s research it appears that in one-third of patients in the study developed a tolerance that blunts the drug’s effectiveness.  The study results were recently presented at the American Epilepsy Society’s annual meeting in New Orleans.

Lead Research/Investigator

Dr. Shimrit Uliel-Sibony

Source: USNews

Pin It on Pinterest